Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Writer's new AI harness study cuts enterprise token spend by 38% and cost per task by 41% across six foundation models, ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...

Oppenheimer says SpaceX/Tesla’s Terafab using Intel 18A is critical to SpaceX valuation—AI & space-hardened chips, $120B risk ...

Stocks slide as semiconductor selloff deepens on AI spending fears, valuations, oil tensions and key data ahead.

Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...